Related Experiment Video
Updated: Aug 11, 2026

A General Method for Detecting Nitrosamide Formation in the In Vitro Metabolism of Nitrosamines by Cytochrome P450s
Published on: September 25, 2017
Mechanisms of nickel carcinogenesis
1Department of Laboratory Medicine, University of Connecticut Medical School, Farmington.
Abstract:
Recent investigations on possible mechanisms of nickel carcinogenesis are reviewed, emphasizing cellular uptake and intracellular translocation of nickel, morphological transformation of cells by nickel compounds, chromosomal damage, DNA strandbreaks and DNA-protein complexes produced by nickel compounds, mutagenic effects of nickel, influence of nickel on the helical transition of B-DNA to Z-DNA, nickel-induced infidelity of DNA synthesis, free radicals and lipid peroxidation induced by nickel exposures, nickel inhibition of DNA repair, nickel as a tumor promotor, nickel inhibition of natural-killer (NK) cell activity, manganese and magnesium antagonism of nickel carcinogenesis, and speculation that Ni2+ might replace Zn2+ in finger-loop domains of transforming proteins. The weight of evidence supports the following tentative conclusions: differences in the carcinogenic activities of nickel compounds may reflect variations in their capacities to provide nickel ions (eg, Ni2+) at critical sites within target cells; Ni2+ can initiate carcinogenesis, possibly by mutagenesis, chromosome damage, formation of Z-DNA, inhibition of DNA excision-repair or epigenetic mechanisms; Ni2+ can function as a tumor promoter; Ni2+ can enhance tumor progression by inhibiting NK cell activity; and nickel carcinogenesis can be suppressed or modified by certain other metals (eg, manganese and magnesium).
More Related Videos
Related Concept Videos
Catalysis
Cancer Prevention
Some...
2° Amines to N-Nitrosamines: Reaction with NaNO2
Mutagenicity and Carcinogenicity
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Bioactivation and Tissue Toxicity

